Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03516266
Recruitment Status : Unknown
Verified April 2018 by Peking Union Medical College Hospital.
Recruitment status was:  Recruiting
First Posted : May 4, 2018
Last Update Posted : May 11, 2018
Sponsor:
Collaborators:
Liuzhou Maternity and Child Healthcare Hospital
Qingdao Municipal Hospital
Zhongshan City People's Hospital
The First Affiliated Hospital with Nanjing Medical University
Second Affiliated Hospital of Soochow University
Maternity and Child Health Hospital of Changsha
Henan Provincial People's Hospital
Huaian Maternal and Child Health Care Hospital
Hunan Provincial Maternal and Child Health Care Hospital
Fourth Hospital of Shijiazhuang City
Shenzhen Luohu District Maternity And Child Healthcare Hospital
Second Affiliated Hospital of Wenzhou Medical University
Hubei Shiyan People's Hospital
Changzhi Maternity & Child Health Hospital
Maternal and Child Health Care Hospital of Xinjiang Uygur Autonomous Region
The First Hospital of Hebei Medical University
Shen-Zhen City Maternity and Child Healthcare Hospital
Dalian Medical University
Maternity and Child Care Center of QinHuangDao City
The People's Hospital of Leshan
Information provided by (Responsible Party):
Peking Union Medical College Hospital

Brief Summary:
This study aims to investigate the status of pelvic floor function of healthy female in China, including premenopausal nullipara, premenopausal women with childbirth and postmenopausal women.

Condition or disease
Pelvic Floor

Detailed Description:
This is a cross-sectional survey. The normal physical examination population is divided into three groups,including premenopausal nullipara, premenopausal women with childbirth and postmenopausal women. The pelvic floor muscle function in three groups are evaluated. The modified Oxford Grading Scale and Levator ani testing is used to quantify PFM strength through vaginal palpation. Pelvic floor muscle strength ,endurance, repetition,vaginal contraction pressure and the knack test are evaluated using a PHENIX USB 8 neuromuscular stimulation therapy system (Company: Vivaltis-Electronic Concept Lignon Innovation, Montpellier, France). In six different regions of China according to geographic region (northwest, southwest, north, east, northeast, and central-south China) , 1 or more hospitals in each area are selected as sub-centers, which needs to complete the evaluation of pelvic floor muscle function of 360 cases in 3 groups totally.

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 7920 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Target Follow-Up Duration: 1 Day
Official Title: A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female
Actual Study Start Date : May 10, 2018
Estimated Primary Completion Date : December 31, 2020
Estimated Study Completion Date : December 31, 2020

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. maximum vaginal contraction pressure [ Time Frame: 1 day ]
    it is measured by manometry, range(80-150cmH2O). The higher values represent better outcomes.


Secondary Outcome Measures :
  1. Pelvic floor muscle strength [ Time Frame: 1 day ]

    The modified Oxford Grading Scale is used to quantify PFM strength through vaginal palpation. range(0-5).The higher values represent better outcomes.

    through vaginal palpation.


  2. Pelvic floor muscle strength(repetition) [ Time Frame: 1 day ]
    Levator ani testing is used to quantify PFM strength. range(0-5). The higher values represent better outcomes.

  3. Pelvic floor muscle contraction endurance [ Time Frame: 1 day ]
    muscle contractions maintained for 0 s are defined as grade 0, 1 s as grade I, 2 s as grade II, 3 s as grade III, 4 s as grade IV, and 5 s or longer as grade V. Normal muscles can maintain the contraction for 5 s. range(0-5s). The higher values represent better outcomes.

  4. pelvic organ prolapse quantification [ Time Frame: 1 day ]
    POP-Q is measured when maximum valsalva. range(0-4). stage 0 represents normal.

  5. the knack test [ Time Frame: 1 day ]
    a voluntary PFM contraction before or during coughing. That the contraction could be performed represents normal.

  6. vaginal rest pressure [ Time Frame: 1 day ]
    measure when no vaginal contraction by manometry. range(25-50 cmH2O). the lower and the higher values represent abnormal outcomes.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Volunteers are divided into three groups, and each clinical center requires at least 120 persons in each group.

Group A: Premenopausal women without history of abortion or delivery.

Group B: Premenopausal women with childbirth (including cesarean section or natural birth).

Group C:Postmenopausal women (except surgical menopause).

Criteria

Inclusion Criteria:

Group A:Premenopausal women without history of abortion or delivery

  1. Having sex life and tolerable to vaginal examination
  2. Premenopausal women without history of abortion over 16 weeks
  3. Premenopausal women without history of childbirth
  4. Planning to live locally for a long time

Group B:Premenopausal women with childbirth

  1. Having sex life and tolerable to vaginal examination
  2. Premenopausal women with childbirth (including cesarean section or natural birth).
  3. Planning to live locally for a long time

Group C:Postmenopausal women (over a year, except surgical menopause)

  1. Having sex life and tolerable to vaginal examination
  2. Postmenopausal women
  3. Planning to live locally for a long time

Exclusion Criteria:

  1. Incontinence 4 weeks before enrollment
  2. History of fecal incontinence
  3. Prolapse beyond the level of the hymen
  4. History of radical operation of pelvic cavity(cervical cancer,rectal cancer,bladder cancer, ect)
  5. History of pelvic radiotherapy
  6. History of pelvic floor surgery
  7. History of abortion over 16 weeks' pregnancy or in 1 year after delivery
  8. Duration of pregnancy
  9. Duration of lactation
  10. History of hysterectomy
  11. Latex allergy
  12. Colpitis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03516266


Contacts
Layout table for location contacts
Contact: Zhijing Sun, MD 13651314354 sunzhj2001@sina.com
Contact: Lan Zhu, MD zhu_julie@vip.sina.com

Locations
Layout table for location information
China, Beiing
Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences Recruiting
Beijing, Beiing, China, 100730
Contact: Zhijing Sun, MD    13651314354    sunzhj2001@sina.com   
Sponsors and Collaborators
Peking Union Medical College Hospital
Liuzhou Maternity and Child Healthcare Hospital
Qingdao Municipal Hospital
Zhongshan City People's Hospital
The First Affiliated Hospital with Nanjing Medical University
Second Affiliated Hospital of Soochow University
Maternity and Child Health Hospital of Changsha
Henan Provincial People's Hospital
Huaian Maternal and Child Health Care Hospital
Hunan Provincial Maternal and Child Health Care Hospital
Fourth Hospital of Shijiazhuang City
Shenzhen Luohu District Maternity And Child Healthcare Hospital
Second Affiliated Hospital of Wenzhou Medical University
Hubei Shiyan People's Hospital
Changzhi Maternity & Child Health Hospital
Maternal and Child Health Care Hospital of Xinjiang Uygur Autonomous Region
The First Hospital of Hebei Medical University
Shen-Zhen City Maternity and Child Healthcare Hospital
Dalian Medical University
Maternity and Child Care Center of QinHuangDao City
The People's Hospital of Leshan
Investigators
Layout table for investigator information
Principal Investigator: Lan Zhu, MD Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences
Additional Information:

Layout table for additonal information
Responsible Party: Peking Union Medical College Hospital
ClinicalTrials.gov Identifier: NCT03516266    
Other Study ID Numbers: JS-1550
First Posted: May 4, 2018    Key Record Dates
Last Update Posted: May 11, 2018
Last Verified: April 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Peking Union Medical College Hospital:
Pelvic floor muscle strength
Premenopausal nullipara
Childbirth
Postmenopausal